Candriam Equities L Oncology Fund Class SF2 Fonds
936,35
EUR
-18,22
EUR
-1,91
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 7,08% |
| AstraZeneca PLC | GB0009895292 | 5,37% |
| Roche Holding AG | CH0012032048 | 4,87% |
| Merck & Co Inc | US58933Y1055 | 4,81% |
| Novartis AG Registered Shares | CH0012005267 | 4,28% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,67% |
| Novo Nordisk AS Class B | DK0062498333 | 3,45% |
| Amgen Inc | US0311621009 | 3,42% |
| Intuitive Surgical Inc | US46120E6023 | 3,13% |
| Pfizer Inc | US7170811035 | 3,00% |
| Sonstige | 56,91% |